Page last updated: 2024-09-02

testosterone 17-glucosiduronate and Substance-Related Disorders

testosterone 17-glucosiduronate has been researched along with Substance-Related Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowers, LD1
Ekström, L; Garle, M; Lundmark, J; Rane, A; Schulze, JJ; Skilving, I1

Other Studies

2 other study(ies) available for testosterone 17-glucosiduronate and Substance-Related Disorders

ArticleYear
Testosterone doping: dealing with genetic differences in metabolism and excretion.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:7

    Topics: Doping in Sports; Epitestosterone; Gas Chromatography-Mass Spectrometry; Genotype; Glucuronosyltransferase; Humans; Male; Minor Histocompatibility Antigens; Reference Values; Substance-Related Disorders; Testosterone

2008
Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:7

    Topics: Adolescent; Adult; Doping in Sports; Epitestosterone; Gas Chromatography-Mass Spectrometry; Gene Dosage; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Minor Histocompatibility Antigens; Sensitivity and Specificity; Substance-Related Disorders; Testosterone

2008
chemdatabank.com